Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [709]
News [2460]
Articles [200]
Editorials [6]
Conferences [89]
elearning [31]
New technique may quickly and accurately predict effective therapies in solid tumours
New technique may quickly and accurately predict effective therapies in solid tumours
Phase II trial leads to practice changing milestone for advanced anal cancer
Phase II trial leads to practice changing milestone for advanced anal cancer
European Commission approves encorafenib in combination with cetuximab for the treatment of adult patients with BRAF V600E-mutant metastatic colorectal cancer
European Commission approves encorafenib in combination with cetuximab for the treatment of adult patients with...
Adherence to oral diabetes drugs may improve survival in diabetics with colorectal cancer
Adherence to oral diabetes drugs may improve survival in diabetics with colorectal cancer
Adherence to oral diabetes drugs may improve survival in diabetics with colorectal cancer
Adherence to oral diabetes drugs may improve survival in diabetics with colorectal cancer
ASCO 2020: Targeted therapy pralsetinib achieves high response rates in advanced cancers with RET gene fusions
ASCO 2020: Targeted therapy pralsetinib achieves high response rates in advanced cancers with RET gene fusions
ASCO 2020: Pembrolizumab doubles time to disease progression in patients with advanced colorectal cancer with specific DNA mutations
ASCO 2020: Pembrolizumab doubles time to disease progression in patients with advanced colorectal cancer with...
ASCO 2020: Early data show cancer progression associated with increased risk of death in patients with COVID-19
ASCO 2020: Early data show cancer progression associated with increased risk of death in patients with COVID-19
New analytic tool designed to help guide precision oncology discovery and treatments
New analytic tool designed to help guide precision oncology discovery and treatments
FDA approves ripretinib for advanced gastrointestinal stromal tumour
FDA approves ripretinib for advanced gastrointestinal stromal tumour

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation